Caroline H Ko

Caroline H Ko is a prominent inventor based in Chicago, IL, known for her groundbreaking work in nanotechnology. With a total of two patents to her name, she has made significant contributions to the field, particularly in the development of nanoconjugates that can effectively cross the blood-brain barrier.

Latest Patents

Her latest patents focus on nanoconjugates that address critical challenges in therapeutic applications. One of her notable inventions is a single-entity, targeted therapeutic that can cross the blood-brain barrier (BBB), making it effective for treating central nervous system (CNS) disorders. These nanoconjugates demonstrate a remarkably high cellular uptake while exhibiting no toxicity in the tested cell types. This characteristic is essential for therapeutic agent delivery, as it helps reduce off-target effects. Another patent also emphasizes the methods of using these nanoconjugates for therapeutic purposes, further showcasing her innovative approach to addressing complex medical challenges.

Career Highlights

Caroline H Ko is affiliated with Northwestern University, where she continues to advance her research in nanotechnology. Her work has garnered attention for its potential to revolutionize treatment options for CNS disorders, highlighting her role as a leading inventor in this specialized field.

Collaborations

She has collaborated with notable colleagues, including Chad A Mirkin and David A Giljohann, who are also recognized for their contributions to nanotechnology and related research areas.

Conclusion

Caroline H Ko's innovative work in developing nanoconjugates that can cross the blood-brain barrier represents a significant advancement in therapeutic applications. Her contributions are paving the way for new treatment options in the medical field, particularly for CNS disorders.

Profile summary based on public USPTO records.